Picture of Biocept logo

BIOC Biocept Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapContrarian

Annual cashflow statement for Biocept, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-21.6-24.6-25.1-17.8-2.82
Depreciation
Non-Cash Items1.240.6142.563.25.54
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.1450.801-1.4-6.27-0.552
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-19.7-22.4-23-19.83.69
Capital Expenditures-1.4-0.145-0.735-0.867-1.57
Purchase of Fixed Assets
Other Investing Cash Flow Items0
Sale of Fixed Assets
Cash from Investing Activities-1.4-0.145-0.735-0.867-1.57
Financing Cash Flow Items0.1510
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities18.623.829.725.712.4
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-2.461.285.885.0714.5

Or unlock with your email

Or unlock with your email